These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29846959)

  • 1. Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews.
    Tay CT; Joham AE; Hiam DS; Gadalla MA; Pundir J; Thangaratinam S; Teede HJ; Moran LJ
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):535-553. PubMed ID: 29846959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
    Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
    Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e817-e836. PubMed ID: 37554096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews.
    Gilbert EW; Tay CT; Hiam DS; Teede HJ; Moran LJ
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):683-699. PubMed ID: 30099747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
    Goldberg A; Graca S; Liu J; Rao V; Witchel SF; Pena A; Li R; Mousa A; Tay CT; Pattuwage L; Teede H; Yildiz BO; Ee C
    Obes Rev; 2024 May; 25(5):e13704. PubMed ID: 38355887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
    Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
    BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
    EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
    Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
    Eur J Endocrinol; 2023 Jul; 189(1):S1-S16. PubMed ID: 37440702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.
    Fontes AFS; Reis FM; Cândido AL; Gomes KB; Tosatti JAG
    Eur J Clin Pharmacol; 2023 Apr; 79(4):445-460. PubMed ID: 36763111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.
    Al Khalifah RA; Flórez ID; Dennis B; Neupane B; Thabane L; Bassilious E
    Syst Rev; 2015 Sep; 4():125. PubMed ID: 26420636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review.
    Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
    Clin Endocrinol (Oxf); 2023 Jul; 99(1):79-91. PubMed ID: 36939017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial.
    Alpañés M; Álvarez-Blasco F; Fernández-Durán E; Luque-Ramírez M; Escobar-Morreale HF
    Eur J Endocrinol; 2017 Nov; 177(5):399-408. PubMed ID: 28912358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the Editor From de Zegher and Ibáñez: "Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis".
    de Zegher F; Ibáñez L
    J Clin Endocrinol Metab; 2024 Sep; 109(10):e1966. PubMed ID: 38779861
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.
    Ghazeeri GS; Nassar AH; Younes Z; Awwad JT
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):658-78. PubMed ID: 22375613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.